Login to Your Account

Genor, Biocnd moving Humira biosimilar into clinical testing

By Cornelia Zou
Staff Writer

Wednesday, August 20, 2014

HONG KONG – A Chinese biopharma has received approval from South Korean regulators to conduct local clinical trials on its biosimilar drug.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription